Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Biotase is an oral digestive enzyme supplement used as an adjuvant treatment for indigestion and various digestive disorders, including symptoms such as bloating, belching, flatulence, abdominal discomfort, or a feeling of fullness. The product contains a combination of enzymes—biodiastase-1000 (30 mg), lipase Ap6 (5 mg), and new lease (10 mg)—which aid in the breakdown of carbohydrates and fats to support digestion. It is typically administered as chewable tablets for both adults and children over 12 years old[1][2][7]. The mechanism of action involves enzymatic hydrolysis of dietary macronutrients to facilitate their absorption in the gastrointestinal tract.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on biotase.